Seran Bioscience

Venture-backed companyseranbio.com

At Serán, we use science-first methodology and cutting-edge drug delivery technologies to enable our client's medicines and improve patients' lives.

Rounds on record
0
More
Ask DFX about thisView relationshipsFinancing historyInvestorsOwnership and outcomes
As of · the latest observation of this company; each round carries its own date

7 additional relationships, 2 additional investors

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

What matters now

  1. 4 investors
    named

    4 investors on record.

    The investors already on the cap table shape who leads the next round.

    Factfunding announcements, portfolio pages and Form DFor Investors, foundersInvestors →
Drawing the relationship network…
Facts
Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
0
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
4
Financing history
0 rounds
No dated round yet.
Investors on record
5 edges
Ownership and outcomes
none on record
Outcome stated by investors

Listed on 5 firm portfolio pages; none states an outcome (acquired, public, exited or active). DFX does not assume the company is active.

Evidence: 5 listingseach firm's own card, as read
  • Status not stated on Bain Capital Life Sciences · the firm's card prints no outcome · read Sep 29, 2026 seranbio.com
    “Biospring Partners joins existing investors Bain Capital Life Sciences and Vivo Capital.”
  • Status not stated on Biospring Management, LLC · the firm's card prints no outcome · read Sep 29, 2026 seranbio.com
    “Serán Bioscience Strengthens Spray Dry Capabilities with Growth Investment From Biospring Partners to Accelerate Commercial Expansion and Meet Surging Customer Demand”
  • Status not stated on LSP Or Life Sciences Partners · the firm's card prints no outcome · read Sep 29, 2026 seranbio.com
    “Biospring Partners joins existing investors Bain Capital Life Sciences and Vivo Capital.”

2 more listings counted above; the firms are named with a plan.

No later owner or exit on record: no private equity sponsor position and no acquisition, listing or IPO report names this company.
Credit relationships
10 positions in BDC schedules, matched to this company
People
0 officers, 0 directors
No officer or director on record.
Timeline
0 events
No dated event on record.
Evidence
5 observations
Every observation on this company
  • Description: Sep 29, 2026 Fact no URL
  • Investors named on site: 4 Sep 29, 2026 Fact no URL
  • Listed on portfolio page: Sep 16, 2026 Fact no URL
  • Website status: ok Sep 29, 2026 Fact no URL
  • Site title: Sep 29, 2026 Fact no URL

Relationships across DFX

on 2 other DFX graphs · 11 capital paths
Across the graphs

Seran Bioscience is the same institution as 2 records in Private Equity and Private Credit.

Private Equity1Private Credit1

DFX found 2 relationships across 2 datasets

Which record it is in each graph, what it is called there, and how the two were matched.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Checking your plan…

Capital chain

Seran Bioscience sits on 11 traced paths of capital across the graphs.

Allocator to VC fund to manager to company

DFX traced 11 paths of capital through this record

Every record on each path, what it committed or lent, and as of when.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Derived from allocator disclosures, BDC schedules and SEC filings; confidence is the weakest hop.

Checking your plan…